Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3

Abstract

TLR3 mediates antiretroviral cytotoxic NK cell and CD8(+) T cell activity in vivo. Our findings qualify TLR3 as target of immune therapy against retroviral infections.